Induction of inducible nitric oxide synthase and apoptosis by LPS and TNF-alpha in nasal microvascular endothelial cells. 2008

Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
Department of Otolaryngology, Kansai Medical University, Moriguchi, Osaka, Japan.

CONCLUSIONS This study demonstrates that the co-administration of lipopolysaccharide (LPS) and tumor necrosis factor-alpha (TNF-alpha) (LPS/TNF-alpha) can induce the expression of inducible nitric oxide synthase (iNOS), which results in the generation of apoptosis in cultured human nasal microvascular endothelial cells (HNMECs). Since LPS and TNF-alpha have been suggested to play an important role in the pathophysiology of nasal disease, we conclude that microvascular leakage may therefore contribute to the inflammatory process in nasal disease, such as allergic rhinitis and asthma. METHODS The HNMECs were obtained from the inferior turbinate and subsequently cultured. The expression of iNOS induced by both the LPS and TNF-alpha was investigated by fluorescent immunohistochemistry, using confocal laser microscopy. The DNA-binding dye, Hoechist 33342, was also used to analyze the apoptosis in the HNMECs. RESULTS The fluorescent immunohistochemistory study demonstrated that LPS and TNF-alpha induced the expression of iNOS in HNMECs. LPS/TNF-alpha remarkably augmented the expression of iNOS in HNMECs in comparison to stimulation by either LPS or TNF-alpha alone. LPS/TNF-alpha also induced apoptosis in HNMECs. 1400W, a highly selective inhibitor of iNOS, inhibited both the expression of iNOS and the apoptosis induced by LPS/TNF-alpha.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
January 1999, Anticancer research,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
October 2010, Biochemical and biophysical research communications,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
November 2000, Life sciences,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
March 1999, The Journal of investigative dermatology,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
June 2001, Journal of immunology (Baltimore, Md. : 1950),
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
October 1991, The American journal of physiology,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
September 1998, Neuroscience letters,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
January 1998, Journal of clinical gastroenterology,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
March 1999, Planta medica,
Shoji Arai, and Narinobu Harada, and Nobuo Kubo, and Jing Shen, and Akihiko Nakamura, and Hiroki Ikeda, and Hiroyuki Tsuji, and Toshio Yamashita
September 2000, International journal of pediatric otorhinolaryngology,
Copied contents to your clipboard!